Dane Leone

Stock Analyst at Raymond James

(1.19)
# 2072
Out of 5,441 analysts
129
Total ratings
Success rate
Average return
42 Stocks
Name Action PT Current % Upside Ratings Updated
RLAY Relay Therapeutics
Maintains: Strong Buy
29 19
3.24 486.42% 3 Aug 8, 2025
XLO Xilio Therapeutics
Maintains: Outperform
6 4
0.68 488.24% 3 Nov 8, 2024
RGNX Regenxbio
Reinstates: Outperform
45
7.46 503.22% 2 Feb 21, 2024
BPMC Blueprint Medicines
Maintains: Strong Buy
85 100
129.46 -22.76% 9 Dec 22, 2023
RVMD Revolution Medicines
Initiates Coverage On: Outperform
30
34.71 -13.57% 1 Nov 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
200 260
4.97 5131.39% 6 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
950
546.18 73.94% 10 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 9
n/a n/a 3 Oct 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
13
2 550% 5 Oct 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
29 46
48.24 -4.64% 2 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
69
31.5 119.05% 5 May 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 8
7.16 11.73% 5 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 8
3.33 140.24% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 14
12.56 11.46% 5 Nov 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
58
7 728.57% 4 Oct 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 70
13.87 404.69% 3 Aug 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 63
33.2 89.76% 2 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Jun 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Apr 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 6
0.53 1032.08% 2 Mar 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
50 65
50.08 29.79% 3 Oct 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 5 Dec 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
255
285.1 -10.56% 3 Oct 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
n/a
n/a n/a 5 Dec 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
32
3.08 938.96% 2 Sep 10, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Aug 28, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 2 Jul 21, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 3 Jun 8, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
58
n/a n/a 1 Dec 22, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 4, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 1, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
n/a n/a 1 Sep 23, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Sep 7, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Sep 5, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Aug 25, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
n/a
n/a n/a 1 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 2 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Aug 15, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
n/a n/a 1 Aug 11, 2016